DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bg5ff3/chronic_kidney) has announced the addition of the "Chronic Kidney Disease (Chronic Renal Failure)-Pipeline Insights" report to their offering.

The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Chronic Kidney Disease (Chronic Renal Failure) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Insights Report covers the Chronic Kidney Disease (Chronic Renal Failure) pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Chronic Kidney Disease (Chronic Renal Failure) related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Chronic Kidney Disease (Chronic Renal Failure).

Scope

- The report provides a Chronic Kidney Disease (Chronic Renal Failure) Landscape across the globe

- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information

- Coverage of the Chronic Kidney Disease (Chronic Renal Failure) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for Chronic Kidney Disease (Chronic Renal Failure) and also provide company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery.

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

For more information visit http://www.researchandmarkets.com/research/bg5ff3/chronic_kidney

...